NPPB and Renal insufficiency: Even NT-proBNP, a well-established clinical biomarker used to rule out HF diagnosis, cannot reliably discriminate CVD pathologies [55] and may be elevated in extracardiac conditions such as renal insufficiency or systemic inflammation [56].